Stock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion

Stock Track04-30

Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.

The sharp rise appears to be driven by the company's recently reported first-quarter financial results, which showed revenue skyrocketing 184.89% year-over-year to RMB 128 million, while net losses narrowed by 17.07%. Additionally, the stock's recent inclusion in the Stock Connect program following its H-share listing has enhanced liquidity by enabling direct participation from mainland investors.

Market attention is also focused on the company's pipeline of ADC and TCE-based oncology therapies, with Phase III interim analyses for its lead candidate expected this year, contributing to positive investor sentiment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109239943?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 09:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109239943","market":"nz","top_or_hot":-1,"title":"Stock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion","media":"Stock Track","content":"<p>Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.</p><p>The sharp rise appears to be driven by the company's recently reported first-quarter financial results, which showed revenue skyrocketing 184.89% year-over-year to RMB 128 million, while net losses narrowed by 17.07%. Additionally, the stock's recent inclusion in the Stock Connect program following its H-share listing has enhanced liquidity by enabling direct participation from mainland investors.</p><p>Market attention is also focused on the company's pipeline of ADC and TCE-based oncology therapies, with Phase III interim analyses for its lead candidate expected this year, contributing to positive investor sentiment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Mabwell Bio Soars 6.44% Intraday on Strong Q1 Revenue Growth and Stock Connect Inclusion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-30 09:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.</p><p>The sharp rise appears to be driven by the company's recently reported first-quarter financial results, which showed revenue skyrocketing 184.89% year-over-year to RMB 128 million, while net losses narrowed by 17.07%. Additionally, the stock's recent inclusion in the Stock Connect program following its H-share listing has enhanced liquidity by enabling direct participation from mainland investors.</p><p>Market attention is also focused on the company's pipeline of ADC and TCE-based oncology therapies, with Phase III interim analyses for its lead candidate expected this year, contributing to positive investor sentiment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02493","symbol_name":"迈威生物-B","start_time":0,"source_url":"","article_id":"1109239943","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109239943","pubTimestamp":1777513802,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.The sharp rise appears to be driven by the company's recently reported...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02493":"迈威生物-B"},"translate_title":"个股追踪|Q1营收强劲增长且纳入沪股通，麦布威尔生物盘中大涨6.44%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02493":1},"content_text":"Mabwell Bio's stock price surged 6.44% during intraday trading on Thursday, marking a significant rebound in its share price.The sharp rise appears to be driven by the company's recently reported first-quarter financial results, which showed revenue skyrocketing 184.89% year-over-year to RMB 128 million, while net losses narrowed by 17.07%. Additionally, the stock's recent inclusion in the Stock Connect program following its H-share listing has enhanced liquidity by enabling direct participation from mainland investors.Market attention is also focused on the company's pipeline of ADC and TCE-based oncology therapies, with Phase III interim analyses for its lead candidate expected this year, contributing to positive investor sentiment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109239943","isCrawlerRequest":true}